EASL 2026
27-30 May 2026 | Barcelona
HistoIndex at the EASL Congress
27-30 May 2026
HistoIndex’s scientific contributions to EASL Congress 2026 included 7 poster presentations:
POSTERS
AI-Derived Macrophage Density Reveals Hot and Cold Fibrosis Endotypes with Distinct Biomarker Profiles in Metabolic Dysfunction–Associated Steatohepatitis
Presenter: Zoltan Derdak
WED-087 | Wednesday, 27 May 2026
MASLD: Diagnostics and non-invasive assessment
Impact of PNPLA3 p.I148M variant on qFibrosis-based collagen morphology in MASLD: analysis from Milan biobank cohort
REG26-774: Efruxifermin improved digital pathology and noninvasive fibrosis measures in participants with MASH and advanced fibrosis or compensated cirrhosis: analysis of the HARMONY and SYMMETRY phase 2b trials
REG26-2279: Quantitative digital pathology reveals distinct fibrosis zonal patterns among subtypes of steatotic liver disease
Presenter: Prof. Dr. Jeong Hwan Park
THU-174 | Thursday, 28 May 2026
MASLD: Clinical aspects except therapy
REG26-3625: Natural history and predictors of fibrosis progression in metabolic dysfunction-associated steatotic liver disease (MASLD) – Longitudinal cohort study with paired liver biopsies
Presenter: Dr. Fahim Ebrahimi
THU-126 | Thursday, 28 May 2026
MASLD: Clinical aspects except therapy
REG26-2637: A spatial metabolic atlas of liver lipid metabolism and fibrosis in metabolic dysfunction-associated steatotic liver disease
Presenter: Mojgan Masoodi
TOP-081 | Wednesday, 27 May 2026
MASLD: Diagnostics and non-invasive assessment
